UNM Contraception Mentoring Program

Do you want to explore the impacts of bias on contraceptive care? Please join us for our first training of 2023!
Practical and Sustainable Steps for Addressing Bias in Contraceptive Care

When: Monday, February 13, 2023, from 10 am to 4 pm
Where: Zoom
How: For info and how to register click here-https://www.eventbrite.com/e/practical-and-sustainable-steps-for-addressing-bias-in-contraceptive-care-registration-479373407767
Includes up to 5.0 credits of free CME

Practical and Sustainable Steps for Addressing Bias in Contraceptive Care This training explores implicit bias and how applying the principles of cultural humility can improve the quality of contraceptive care.

Can’t make it to our in-person November training? We are offering similar sessions in February 2023! Obtain up to 5.5 credits of free CME.

Register for free: https://ucsf.zoom.us/meeting/register/tJIsde2prT4jGNzH299rQzOjNbk81_t2PnTs?fbclid=IwAR3yscjq0JOSXOzD1zjOXSch9gFTRD-8F56eVzm-x3hm4Atyf8K6-NLv3cE

Welcome! You are invited to join a meeting: Expanding Reproductive Autonomy and Contraceptive Access. After registering, you will receive a confirmation email about joining the meeting. The UCSF Beyond the Pill program and the University of New Mexico LARC Mentoring Program are pleased to bring you this interactive virtual training. The training is certified for up to 5.5 CME credit hours at no cost and open to all clinic staff. Event Schedule: 10:00am-12:00pm MT Contraceptive Coun...

https://providers.bedsider.org/articles/top-reasons-the-birth-control-pill-should-be-otc?fbclid=IwAR1tHlacKqZwJZlFwxk5ZnoUlTYOFlXkXMMQjmJBvdzffyZXKHOSPSwovEo

Top reasons the birth control pill should be OTC Hear more from Power to Decide's CEO Dr. Raegan McDonald-Mosley and join our movement to

https://www.npr.org/sections/health-shots/2022/07/14/1111297318/over-the-counter-birth-control-pills

Over-the-counter birth control pills are available worldwide. The U.S. may be next Birth control pills are available in the U.S. only with a prescription. Now a drugmaker is asking the FDA to approve a progestin-only contraceptive that would be available without one at pharmacies.